On the left eye, the patient had conjunctival congestion and hyperemia, a central 2- × 2-mm corneal epithelial defect with deep stromal infiltration, endothelial plaque, moderate anterior chamber ...

Lufepirsen is under clinical development by Amber Ophthalmics and currently in Phase II for Persistent Corneal Epithelial Defects. According to GlobalData, Phase II drugs for Persistent Corneal ...

Crizanlizumab is under clinical development by Novartis and currently in Phase II for Chronic Kidney Disease (Chronic Renal Failure). According to GlobalData, Phase II drugs for Chronic Kidney Disease ...

He received a topical treatment. Two months later, he underwent conjunctival flap surgery for a corneal ulcer that did not heal. He was wearing therapeutic contact lenses and using cyclopentolate 1%, ...

When the integrity of the neurovascular bundle has been thus assured the island flap is circumscribed and dissected free from the bony phalanx. The original defect is then freshened surgically ...

The rabbits’ a-SMA myofibroblasts were high at the endpoint. Group 2 rabbits completed 30 days of treatment, but 5 rabbits’ corneas experienced persistent epithelial defects (PEDs) and increasing ...

From January 2010 to June 2014, we evaluated 12 cases of CPs that were surgically treated using the advanced musculocutaneous scrotal flap technique after degloving through a ventral approach.

The approval and commercialization of Oxervate (cenegermin-bkbj, Dompé) in the United States has improved our ability to treat corneal persistent epithelial defects (PEDs) or corneal ...

from the initial signs of mild staining to a persistent epithelial defect until the disease progresses to the more advanced stages of corneal thinning of the stroma. But the stroma can be even ...

The FDA notes the reason for this recall as a packaging defect. As their report explains ... the patients with signs and symptoms of bacterial conjunctivitis and positive conjunctival cultures were ...